U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H22N2S.C2H4O2
Molecular Weight 370.508
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PECAZINE ACETATE

SMILES

CC(O)=O.CN1CCCC(CN2C3=C(SC4=C2C=CC=C4)C=CC=C3)C1

InChI

InChIKey=COBIOCPXKOZHSU-UHFFFAOYSA-N
InChI=1S/C19H22N2S.C2H4O2/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21;1-2(3)4/h2-5,8-11,15H,6-7,12-14H2,1H3;1H3,(H,3,4)

HIDE SMILES / InChI
PECAZINE is a phenothiazine derivative that was used as an antipsychotic. It is also an allosteric inhibitor of MALT1 paracaspase activity.

Approval Year

Doses

Doses

DosePopulationAdverse events​
75 mg 3 times / day multiple, oral
Recommended
Dose: 75 mg, 3 times / day
Route: oral
Route: multiple
Dose: 75 mg, 3 times / day
Sources: Page: p.729
unhealthy, 20-59
n = 33
Health Status: unhealthy
Condition: schizophrenia
Age Group: 20-59
Sex: F
Population Size: 33
Sources: Page: p.729
Disc. AE: Agranulocytosis...
AEs leading to
discontinuation/dose reduction:
Agranulocytosis (3%)
Sources: Page: p.729
50 mg 3 times / day multiple, oral
Recommended
Dose: 50 mg, 3 times / day
Route: oral
Route: multiple
Dose: 50 mg, 3 times / day
Sources:
unhealthy, 35
n = 1
Health Status: unhealthy
Condition: depisssion
Age Group: 35
Sex: F
Population Size: 1
Sources:
Disc. AE: Agranulocytosis...
AEs leading to
discontinuation/dose reduction:
Agranulocytosis
Sources:
300 mg multiple, oral
Recommended
Dose: 300 mg
Route: oral
Route: multiple
Dose: 300 mg
Sources: Page: p.80
unhealthy, 37.1±1.5
n = 50
Health Status: unhealthy
Condition: schizophrenia
Age Group: 37.1±1.5
Sex: M+F
Population Size: 50
Sources: Page: p.80
Disc. AE: Cycloplegia...
AEs leading to
discontinuation/dose reduction:
Cycloplegia (4%)
Sources: Page: p.80
900 mg multiple, oral
Highest studied dose
Dose: 900 mg
Route: oral
Route: multiple
Dose: 900 mg
Sources: Page: p.144
unhealthy
n = 2
Health Status: unhealthy
Condition: schizophrenia
Population Size: 2
Sources: Page: p.144
25 mg 3 times / day multiple, oral
Studied dose
Dose: 25 mg, 3 times / day
Route: oral
Route: multiple
Dose: 25 mg, 3 times / day
Sources: Page: p.144
unhealthy
n = 2
Health Status: unhealthy
Condition: schizophrenia
Population Size: 2
Sources: Page: p.144
Disc. AE: Jaundice...
AEs leading to
discontinuation/dose reduction:
Jaundice
Sources: Page: p.144
AEs

AEs

AESignificanceDosePopulation
Agranulocytosis 3%
Disc. AE
75 mg 3 times / day multiple, oral
Recommended
Dose: 75 mg, 3 times / day
Route: oral
Route: multiple
Dose: 75 mg, 3 times / day
Sources: Page: p.729
unhealthy, 20-59
n = 33
Health Status: unhealthy
Condition: schizophrenia
Age Group: 20-59
Sex: F
Population Size: 33
Sources: Page: p.729
Agranulocytosis Disc. AE
50 mg 3 times / day multiple, oral
Recommended
Dose: 50 mg, 3 times / day
Route: oral
Route: multiple
Dose: 50 mg, 3 times / day
Sources:
unhealthy, 35
n = 1
Health Status: unhealthy
Condition: depisssion
Age Group: 35
Sex: F
Population Size: 1
Sources:
Cycloplegia 4%
Disc. AE
300 mg multiple, oral
Recommended
Dose: 300 mg
Route: oral
Route: multiple
Dose: 300 mg
Sources: Page: p.80
unhealthy, 37.1±1.5
n = 50
Health Status: unhealthy
Condition: schizophrenia
Age Group: 37.1±1.5
Sex: M+F
Population Size: 50
Sources: Page: p.80
Jaundice Disc. AE
25 mg 3 times / day multiple, oral
Studied dose
Dose: 25 mg, 3 times / day
Route: oral
Route: multiple
Dose: 25 mg, 3 times / day
Sources: Page: p.144
unhealthy
n = 2
Health Status: unhealthy
Condition: schizophrenia
Population Size: 2
Sources: Page: p.144
PubMed

PubMed

TitleDatePubMed
Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.
2010 Mar 3
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011 Jul 14
Name Type Language
PECAZINE ACETATE
Common Name English
NND 1964
Code English
PHENOTHIAZINE, 10-((1-METHYL-3-PIPERIDYL)METHYL)-, MONOACETATE
Systematic Name English
10-((1-METHYL-3-PIPERIDYL)METHYL)PHENOTHIAZINE ACETATE
Systematic Name English
10H-PHENOTHIAZINE, 10-((1-METHYL-3-PIPERIDINYL)METHYL)-, ACETATE (1:1)
Systematic Name English
MEPAZINE ACETATE
Common Name English
10-((1-METHYL-3-PIPERIDYL)METHYL)-10H-PHENOTHIAZINE MONOACETATE
Systematic Name English
PHENOTHIAZINE, 10-((1-METHYL-3-PIPERIDYL)METHYL)-, ACETATE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66883
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID80947227
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY
PUBCHEM
2834213
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY
FDA UNII
U42703EIIO
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY
ECHA (EC/EINECS)
246-207-1
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY
CAS
24360-97-2
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY
NCI_THESAURUS
C75986
Created by admin on Fri Dec 15 15:03:22 GMT 2023 , Edited by admin on Fri Dec 15 15:03:22 GMT 2023
PRIMARY